In conclusion, the present study revealed that 8PG is a novel AMPK activator from CGJ and is associated with inhibiting lipid accumulation and enhancing β-oxidation through the SIRT1-mediated pathway, thereby attenuating hepatic steatosis. This evidence concerns the gene SIRT1 and fatty liver disease.